Overview
The purpose of this clinical trial is to understand the effect of percutaneous acupoint electrical stimulation on postoperative gastrointestinal dysfunction. It will also investigate the safety of percutaneous acupoint electrical stimulation. The main questions that this trial aims to answer are:
Can percutaneous acupoint electrical stimulation alleviate postoperative gastrointestinal dysfunction? Through which mechanisms do they function?
Participants will:
Preoperatively, patients were either given or not given percutaneous acupoint electrical stimulation.
Record their symptoms and biological indicators within 5 days after the operation.
Eligibility
Inclusion Criteria:
- Age \> 18 years
- BMI \< 28 kg/m2
- ASA classification is I-III grade
- Laparoscopic urological procedures under general anesthesia, including but not limited to laparoscopic nephrectomy and laparoscopic radical prostatectomy for prostate cancer
- Normal comprehension ability, and the patient or his/her family members can cooperate in filling out the questionnaire
- Voluntary to sign the informed consent form
Exclusion Criteria:
- Comprehensive assessment of severe cardiovascular, pulmonary and cerebrovascular diseases (such as severe coronary heart disease, valve diseases, respiratory failure, cerebral hemorrhage, cerebral infarction, etc.)
- Preoperative use of analgesic and gastrointestinal motility drugs
- TEAS contraindications (having electronic devices in the body, skin damage or infection at the stimulation site)
- Previous history of TEAS or electro-acupuncture treatment
- Previous history of gastrointestinal surgery, long-term gastrointestinal motility disorders and severe intestinal diseases
- Pregnancy
